Similar sites
Category
N/AGlobal Rank
N/ARank in 1 month
1.1KEstimate Value
N/ASorry. Description is not currently available
#österreich
#enigma
#portal tirol
#enigma funktionsweise
#aufgabenfuchs
#a-trust
#handy signatur
#a trust
#a trust pdf signieren
#id austria
#bürgerkarte
#bürgerkarte aktivieren
#finanzonline
#pdf signieren
#ögk login
#handy signatur neues smartphone
#handysignatur verlängern
#handy signatur aktivierung
#handysignatur
#handy signatur aktivieren
#handysignatur beantragen
#kostenlose
#bildung
#schule
#grundschule
#arbeitsblätter
#lernen
Category
N/AGlobal Rank
N/ARank in 1 month
0Estimate Value
N/A
Malware Scan Info
Macafee Check : 
Email address with tibsovopro.com
Recent Searched Sites
Pictoncastle.co.uk (36 seconds ago) / GB
Duddelas.com (1 seconds ago) / US
Broadbandcheck.co.uk (6 seconds ago) / US
Skdevelopmentsky.com (44 seconds ago) / US
Bbesocialmedia.com (1 mins ago) / US
Playitsafeplaygrounds.com (1 mins ago) / US
Arami-writing.ir (59 seconds ago) / IR
Prapanenterprises.com (1 mins ago) / DE
Forum.reynaulds.com (2 mins ago) / US
Gazetaph.ro (16 seconds ago) / US
Whatreallyhappened.net (2 seconds ago) / US
Cobos.law (1 mins ago) / US
Drmax.eu (2 mins ago) / US
Riverschool.net (38 seconds ago) / US
Tibsovopro.com (0 seconds ago) / US
Etoblog.info (14 seconds ago) / JP
Obrasraras.fiocruz.br (16 seconds ago) / BR
Relais-santa-croce-hotel-florence.hotelmix.it (1 mins ago) / US
Umk-spo.biz (15 seconds ago) / RU
Alisifa.com (44 seconds ago) / US
Domain Informations
Tibsovopro.com lookup results from whois.markmonitor.com server:
- Domain created: 2018-01-08T20:26:10Z
- Domain updated: 2023-12-08T09:50:21Z
- Domain expires: 2026-01-08T20:26:10Z 1 Year, 240 Days left
- Website age: 6 Years, 124 Days
- Registrar Domain ID: 2210602229_DOMAIN_COM-VRSN
- Registrar Url: http://www.markmonitor.com
- Registrar WHOIS Server: whois.markmonitor.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: +1.2086851750
- Name server:
- NS1.MARKMONITOR.COM
- NS2.MARKMONITOR.COM
- NS3.MARKMONITOR.COM
- NS4.MARKMONITOR.COM
- NS5.MARKMONITOR.COM
- NS6.MARKMONITOR.COM
- NS7.MARKMONITOR.COM
Network
- inetnum : 54.90.0.0 - 54.91.255.255
- name : AMAZON-IAD
- handle : NET-54-90-0-0-1
- status : Reallocated
- created : 2018-04-25
- changed : 2019-08-02
Owner
- organization : Amazon Data Services NoVa
- handle : ADSN-1
- address : Array,Herndon,VA,20171,US
Abuse
- handle : AEA8-ARIN
- name : Amazon EC2 Abuse
- phone : +1-206-555-0000
- email : [email protected]
Technical support
- handle : ANO24-ARIN
- name : Amazon EC2 Network Operations
- phone : +1-206-555-0000
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 680706 |
| namecheap.com | 224184 |
| networksolutions.com | 165998 |
| tucows.com | 138228 |
| publicdomainregistry.com | 88771 |
| whois.godaddy.com | 62305 |
| enomdomains.com | 58590 |
| namesilo.com | 49131 |
| cloudflare.com | 48249 |
| gmo.jp | 46138 |
| register.com | 39207 |
| fastdomain.com | 38533 |
| ionos.com | 33836 |
| name.com | 32521 |
| wildwestdomains.com | 32329 |
| net.cn | 31283 |
| registrar.amazon.com | 30188 |
| dynadot.com | 27527 |
| key-systems.net | 27174 |
Host Informations
| Host name | ec2-54-91-6-89.compute-1.amazonaws.com |
| IP address | 54.91.6.89 |
| Location | Ashburn United States |
| Latitude | 39.0481 |
| Longitude | -77.4728 |
| Metro Code | 511 |
| Timezone | America/New_York |
| Postal | 20149 |
Port Scanner (IP: 54.91.6.89)
Spam Check (IP: 54.91.6.89) › Dnsbl-1.uceprotect.net:
› Dnsbl-2.uceprotect.net:
› Dnsbl-3.uceprotect.net:
› Dnsbl.dronebl.org:
› Dnsbl.sorbs.net:
› Spam.dnsbl.sorbs.net:
› Bl.spamcop.net:
› Recent.dnsbl.sorbs.net:
› All.spamrats.com:
› B.barracudacentral.org:
› Bl.blocklist.de:
› Bl.emailbasura.org:
› Bl.mailspike.org:
› Bl.spamcop.net:
› Cblplus.anti-spam.org.cn:
› Dnsbl.anticaptcha.net:
› Ip.v4bl.org:
› Fnrbl.fast.net:
› Dnsrbl.swinog.ch:
› Mail-abuse.blacklist.jippg.org:
› Singlebl.spamgrouper.com:
› Spam.abuse.ch:
› Spamsources.fabel.dk:
› Virbl.dnsbl.bit.nl:
› Cbl.abuseat.org:
› Dnsbl.justspam.org:
› Zen.spamhaus.org:
Keyword Suggestion
Site Inspections
Websites Listing
We found Websites Listing below when search with tibsovopro.com on Search Engine
TIBSOVO® (ivosidenib tablets) an IDH1 Inhibitor
Now approved in combination with azacitidine. For patients with newly diagnosed aml. TIBSOVO ® is an isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for patients with a susceptible …
Tibsovopro.comDA: 18 PA: 18 MOZ Rank: 19
MEDICATION GUIDE TIBSOVO
MEDICATION GUIDE TIBSOVO® (tib-SOH-voh) (ivosidenib tablets) What is the most important information I should know about TIBSOVO? TIBSOVO may cause serious side effects, including:
Tibsovo.comDA: 15 PA: 24 MOZ Rank: 40
A New Frontier in Cholangiocarcinoma Management and Treatment
To learn more about TIBSOVO in cholangiocarcinoma, visit www.tibsovopro.com. For support after being prescribed TIBSOVO, visit www.servierone.com. References. 1. Saha …
Onclive.comDA: 15 PA: 50 MOZ Rank: 84
セルヴィエが、TIBSOVO（R）（イボシデニブ錠）のアザシチジ …
AsiaNet 90964（1782） 【パリ、ボストン2021年8月2日PR Newswire=共同通信JBN】 ＊本試験は未治療のIDH1変異陽性急性骨髄性白血病患者が対象 ＊TIBSO...
Kyodonewsprwire.jpDA: 18 PA: 21 MOZ Rank: 42
Ivosidenib (Tibsovo®) for the treatment of relapsed and ... - PSHP
Ivosidenib (Tibsovo®) for the treatment of relapsed and refractory acute myeloid leukemia in patients with an isocitrate dehydrogenase 1 (IDH1) mutation. Ari Marie Leland, …
Pshp.orgDA: 12 PA: 14 MOZ Rank: 30
TIBSOVO（R）（イボシデニブ錠）のアザシチジン併用第3相試験 …
AsiaNet 93632 （3193） 【パリ、ボストン2021年12月11日PR Newswire=共同通信JBN】 ＊TIBSOVOとアザシチジンの併用療法は、プラセボとアザシチジンの併用療法と比 …
Kyodonewsprwire.jpDA: 18 PA: 21 MOZ Rank: 44
Ivosidenib and Azacitidine in IDH1-Mutated Acute Myeloid …
The performance of the control group is consistent with previous reports indicating poor outcomes with azacitidine in patients with IDH1 -mutated acute myeloid leukemia. 4 Overall, the …
Nejm.orgDA: 12 PA: 31 MOZ Rank: 49
セルヴィエが、TIBSOVO（R）（イボシデニブ錠）のアザシチジ …
AsiaNet 90964（1782） 【パリ、ボストン2021年8月2日PR Newswire=共同通信JBN】 ＊本試験は未治療のIDH1変異陽性急性骨髄性白血病患者が対象 ＊TIBSOVOは、アザシチジンと併用 …
Kyodo.co.jpDA: 15 PA: 23 MOZ Rank: 45
HIGHLIGHTS OF PRESCRIBING INFORMATION - RxAbbVie
3 In Combination with Obinutuzumab Start obinutuzumab administration at 100 mg on Cycle 1 Day 1, followed by 900 mg on Cycle 1 Day 2. Administer 1000 mg on Days 8 and 15 of Cycle …
Rxabbvie.comDA: 16 PA: 50 MOZ Rank: 42
Tib-stil.com Site
Tib-stil.com.This domain provided by namecheap.com at T06:53:29Z (6 Years, 340 Days ago), expired at 2022-08-05T06:53:29Z (0 Years, 24 Days left). Site is …
Caroline.fluxus.orgDA: 19 PA: 14 MOZ Rank: 42
Servier gibt die FDA-Zulassung von TIBSOVO® (Ivosidenib …
Servier gibt die FDA-Zulassung von TIBSOVO® (Ivosidenib-Tabletten) in Kombination mit Azacitidin für Patienten mit neu diagnostizierter IDH1-mutierter akuter …
Wallstreet-online.deDA: 24 PA: 50 MOZ Rank: 40
Servier gibt die FDA-Zulassung von TIBSOVO® (Ivosidenib …
Boston (OTS) – TIBSOVO ist die erste Therapie, die auf den Krebsstoffwechsel abzielt und in Kombination mit Azacitidin für Patienten mit neu diagnostizierter IDH1-mutierter …
Brandaktuell.atDA: 15 PA: 50 MOZ Rank: 39
Current and Emerging Targeted Approaches for Treating Acute
June 15, 2018. Abstract PF227. Rousselot P, et al. Consolidation therapy with ponatinib in combination with cytarabine in patients for FLT3-ITD acute myeloid leukemia in …
Medscape.orgDA: 16 PA: 19 MOZ Rank: 47
IDH Inhibitors in the Management of Acute Myeloid Leukemia: …
1936-P IDH Inhibitors in the Management of Acute Myeloid Leukemia: Focus on Safety and Efficacy References Abou Dalle I, DiNardo CD.
Power-pak.comDA: 13 PA: 37 MOZ Rank: 63
EX-99.2
Time Speaker 8:00 - 8:15 a.m. Opening Remarks – David Schenkein, M.D., Chief Executive Officer Research 8:15 - 9:00 a.m. Discovery Strategy & Research Portfolio – Scott Biller, …
Sec.govDA: 11 PA: 50 MOZ Rank: 90
2021 ASH Annual Meeting
Phone 202-776-0544 Toll Free 866-828-1231 Fax 202-776-0545
Events.jspargo.comDA: 18 PA: 25 MOZ Rank: 58
Episode – Podcast SoundBites
Please listen to additional safety information for TIBSOVO® (ivosidenib tablets) at the end of this presentation. Please visit TibsovoPro.com to review the Full Prescribing Information, …
Podcastsoundbites.comDA: 21 PA: 26 MOZ Rank: 63
Recognizing and Managing Differentiation Syndrome in non-APL …
Target Audience and Goal Statement. This activity is intended for hematologists and oncologists. The goal of this activity is to present practical information and strategies to …
Medscape.orgDA: 16 PA: 19 MOZ Rank: 52
Novel molecules used in the targeted treatment of acute myeloid ...
Authors: J. Vedrová 1; Z. Ráčil 1,2 Authors‘ workplace: Ústav hematologie a krevní transfuze, Praha 1; LF MU, Brno 2 Published in: Transfuze Hematol. dnes,27 ...
Prolekare.czDA: 16 PA: 50 MOZ Rank: 32
Ivosidenib induces deep durable remissions in patients with newly ...
Ivosidenib (AG-120) is an oral, targeted agent that suppresses production of the oncometabolite 2-hydroxyglutarate via inhibition of the mutant isocitrate dehydrogenase 1 …
Researchgate.netDA: 20 PA: 50 MOZ Rank: 31
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| iacoustics.net | enomdomains.com | 1 Year, 324 Days |
| phildiamond.com | networksolutions.com | 2 Years, 83 Days |
| jeffreykeisler.com | publicdomainregistry.com | 5 Years, 192 Days |
| africantrade.info | nic.ru | 24 Days |
| indusinvest.com | publicdomainregistry.com | 48 Days |
| skimccauley.com | spaceship.com | 249 Days |
| tqoftheday.com | networksolutions.com | 4 Years, 321 Days |
| yashagupta.com | bigrock.com | 280 Days |
| fishkill-ny.gov | get.gov | 1 Year, 140 Days |
| sarasotacourtreporters.com | enomdomains.com | 341 Days |